Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polyps 2Hyperplasia 2Colorectal Neoplasms 2Weight Loss 1Psoriasis 1Osteoarthritis 1Colitis, Ulcerative 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1Cancer Cachexia 1Cachexia 1Breast Neoplasms 1Autoimmune Diseases 1Arthritis, Rheumatoid 1Anorexia 1Adenomatous Polyps 1Adenomatous Polyposis Coli 1

Interventions

macimorelin 1RC-1291 1Omacor 1Isophane Insulin, Human 1Eicosapentaenoic Acid 1Docosahexaenoic Acids 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Cancer Cachexia × Eicosapentaenoic Acid × Clear all
NCT00815685 2017-03-23

A Pilot Study of Eicosapentaenoic Acid (EPA) in Patients With Cancer Cachexia

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Completed
36 enrolled 7 charts

Cancer Cachexia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡